{"id":46117,"date":"2017-03-21T23:33:29","date_gmt":"2017-03-22T04:33:29","guid":{"rendered":"https:\/\/3768346-fork.findlaw4.flsitebuilder.com\/?p=46117"},"modified":"2017-03-21T23:33:29","modified_gmt":"2017-03-22T04:33:29","slug":"the-seiden-group-announces-u-s-shareholders-formation-of-a-group-to-recover-investor-funds-through-a-possible-receivership-over-china-based-huifeng-bio-pharmaceutical-technology-inc-ticker_-hfgb","status":"publish","type":"post","link":"https:\/\/seidenlaw.com\/he\/blog\/2017\/03\/the-seiden-group-announces-u-s-shareholders-formation-of-a-group-to-recover-investor-funds-through-a-possible-receivership-over-china-based-huifeng-bio-pharmaceutical-technology-inc-ticker_-hfgb\/","title":{"rendered":"The Seiden Law Announces U.S. Shareholders Formation Of A Group To Recover Investor Funds Through A Possible Receivership Over China-Based Huifeng Bio-Pharmaceutical Technology, Inc (Ticker_ HFGB)"},"content":{"rendered":"<p><strong>Huifeng Bio-Pharmaceutical Technology, Inc.\u00a0<\/strong>(Ticker: HFGB), is a\u00a0British Virgin Islands\u00a0corporation involved in the business of manufacturing and marketing pharmaceutical raw materials and ingredients, such as pharmaceuticals used for human and animals, nutraceuticals, cosmetics, functional drink and food. HFGB was de-listed from the NASDAQ in\u00a0January 2013\u00a0after it stopped reporting to the Securities &amp; Exchange Commission (\u201cSEC\u201d).<\/p>\n<p>Certain shareholders have spoken with Robert W. Seiden, Esq. in New York to represent a group of shareholders to enforce the rights of the U.S. shareholders for acts detrimental to the investors including failure to report to the SEC in order to get a possible return of capital to the investors. . .<\/p>\n<p><a href=\"https:\/\/www.prnewswire.com\/news-releases\/the-seiden-group-announces-us-shareholders-formation-of-a-group-to-recover-investor-funds-through-a-possible-receivership-over-china-based-huifeng-bio-pharmaceutical-technology-inc-ticker-hfgb-300427371.html\" target=\"_blank\" rel=\"noopener\">Read More<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Huifeng Bio-Pharmaceutical Technology, Inc.\u00a0(Ticker: HFGB), is a\u00a0British Virgin Islands\u00a0corporation involved in the business of manufacturing and marketing pharmaceutical raw materials and ingredients, such as pharmaceuticals&hellip;<\/p>","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12],"tags":[],"class_list":["post-46117","post","type-post","status-publish","format-standard","hentry","category-firm-news"],"acf":[],"_links":{"self":[{"href":"https:\/\/seidenlaw.com\/he\/wp-json\/wp\/v2\/posts\/46117","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/seidenlaw.com\/he\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/seidenlaw.com\/he\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/seidenlaw.com\/he\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/seidenlaw.com\/he\/wp-json\/wp\/v2\/comments?post=46117"}],"version-history":[{"count":0,"href":"https:\/\/seidenlaw.com\/he\/wp-json\/wp\/v2\/posts\/46117\/revisions"}],"wp:attachment":[{"href":"https:\/\/seidenlaw.com\/he\/wp-json\/wp\/v2\/media?parent=46117"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/seidenlaw.com\/he\/wp-json\/wp\/v2\/categories?post=46117"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/seidenlaw.com\/he\/wp-json\/wp\/v2\/tags?post=46117"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}